Oliverio Vt
About
In The Last Decade
Oliverio Vt
9 papers receiving 381 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 258
- Oncology 235
- Pulmonary and Respiratory Medicine 55
- Neurology 41
- Genetics 40
Countries citing papers authored by Oliverio Vt
This map shows the geographic impact of Oliverio Vt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliverio Vt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliverio Vt more than expected).
Fields of papers citing papers by Oliverio Vt
This network shows the impact of papers produced by Oliverio Vt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliverio Vt. The network helps show where Oliverio Vt may publish in the future.
Co-authorship network of co-authors of Oliverio Vt
This figure shows the co-authorship network connecting the top 25 collaborators of Oliverio Vt. A scholar is included among the top collaborators of Oliverio Vt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliverio Vt. Oliverio Vt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Clinical pharmacology of anticancer drugs. | 73 |
| 2 | Pharmacology of the nitrosoureas: an overview. | 30 |
| 3 | Toxicology and pharmacology of the nitrosoureas. | 43 |
| 4 | Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle. | 8 |
| 5 | Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). | 227 |
| 6 | A fluorometric method for determination of camptothecin in plasma and urine. | 5 |
| 7 | SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213). | 20 |
| 8 | CARCINOGENIC ACTIVITY OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213). | 21 |
| 9 | Pharmacology of folic acid antagonists as related to brain and cerebrospinal fluid. | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.